Skip to content
PICO Portalanswers from OpenAlex

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

PaperCitations, authors & open-access status

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is a paper indexed in PICO Portal from OpenAlex.

How many citations does miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes have?

PICO Portalcitation count

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has 357 citations in the OpenAlex counts PICO Portal stores.

When was miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes published?

PICO Portalyear

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has 2013 year in the PICO Portal index.

What is the open-access status of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?

PICO Portaloa status

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has bronze oa status in the PICO Portal index.

What is the DOI of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?

PICO Portaldoi

The DOI for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.

What is the PMID of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?

PICO Portalpmid

The PMID for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.

What is the OpenAlex record for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?

PICO Portalopenalex

The OpenAlex for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial